title: Reply to Rubino et al.
authors.affiliation: Bristol Heart Institute, University of Bristol, Bristol, UK.
authors.forename: Antonio
authors.initials: A
authors.lastname: Miceli
authors.affiliation: Bristol Heart Institute, University of Bristol, Bristol, UK g.d.angelini@bristol.ac.uk.
authors.forename: Gianni D
authors.initials: GD
authors.lastname: Angelini
mesh_terms: D001241:Aspirin / Q000008:administration & dosage*; D001026:Coronary Artery Bypass / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000453:epidemiology*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage*; D011183:Postoperative Complications / Q000453:epidemiology*; D013988:Ticlopidine / Q000031:analogs & derivatives*
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin
keywords: Aspirin; Clopidogrel; Platelet